WMS Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-657
| Closed | -$272K | – | 123 |
|
|
2024
Q4 | $272K | Buy |
657
+2
| +0.3% | +$877 | 0.02% | 253 |
|
|
2024
Q3 | $331K | Sell |
655
-398
| -38% | -$193K | 0.02% | 217 |
|
|
2024
Q2 | $513K | Sell |
1,053
-11
| -1% | -$5.52K | 0.03% | 153 |
|
|
2024
Q1 | $574K | Buy |
1,064
+11
| +1% | +$6.01K | 0.04% | 147 |
|
|
2023
Q4 | $584K | Buy |
1,053
+8
| +0.8% | +$3.76K | 0.04% | 141 |
|
|
2023
Q3 | $457K | Sell |
1,045
-49
| -4% | -$24.4K | 0.04% | 160 |
|
|
2023
Q2 | $549K | Sell |
1,094
-20
| -2% | -$9.58K | 0.04% | 150 |
|
|
2023
Q1 | $557K | Sell |
1,114
-44
| -4% | -$21.1K | 0.05% | 141 |
|
|
2022
Q4 | $472K | Sell |
1,158
-17
| -1% | -$6.6K | 0.05% | 161 |
|
|
2022
Q3 | $383K | Buy |
1,175
+32
| +3% | +$11.8K | 0.05% | 164 |
|
|
2022
Q2 | $401K | Buy |
1,143
+10
| +0.9% | +$4.08K | 0.06% | 158 |
|
|
2022
Q1 | $620K | Sell |
1,133
-455
| -29% | -$239K | 0.09% | 118 |
|
|
2021
Q4 | $1.05M | Buy |
1,588
+300
| +23% | +$188K | 0.22% | 75 |
|
|
2021
Q3 | $801K | Sell |
1,288
-43
| -3% | -$28.9K | 0.12% | 102 |
|
|
2021
Q2 | $841K | Sell |
1,331
-2
| -0.2% | -$1.1K | 0.12% | 93 |
|
|
2021
Q1 | $652K | Sell |
1,333
-62
| -4% | -$31.1K | 0.15% | 94 |
|
|
2020
Q4 | $697K | Buy |
1,395
+27
| +2% | +$12.1K | 0.12% | 97 |
|
|
2020
Q3 | $538K | Sell |
1,368
-61
| -4% | -$22.6K | 0.1% | 108 |
|
|
2020
Q2 | $472K | Buy |
1,429
+169
| +13% | +$48.9K | 0.1% | 112 |
|
|
2020
Q1 | $305K | Hold |
1,260
| – | – | 0.08% | 140 |
|
|
2019
Q4 | $329K | Sell |
1,260
-7
| -0.6% | -$1.84K | 0.07% | 169 |
|
|
2019
Q3 | $345K | Hold |
1,267
| – | – | 0.08% | 159 |
|
|
2019
Q2 | $349K | Hold |
1,267
| – | – | 0.09% | 148 |
|
|
2019
Q1 | $283K | Sell |
1,267
-12
| -0.9% | -$2.48K | 0.07% | 154 |
|
|
2018
Q4 | $238K | Hold |
1,279
| – | – | 0.07% | 161 |
|
|
2018
Q3 | $319K | Hold |
1,279
| – | – | 0.04% | 157 |
|
|
2018
Q2 | $279K | Hold |
1,279
| – | – | 0.03% | 171 |
|
|
2018
Q1 | $245K | Sell |
1,279
-8
| -0.6% | -$1.48K | 0.03% | 188 |
|
|
2017
Q4 | $201K | Sell |
1,287
-296
| -19% | -$46.6K | 0.02% | 226 |
|
|
2017
Q3 | $246K | Hold |
1,583
| – | – | 0.03% | 187 |
|
|
2017
Q2 | $256K | Buy |
1,583
+4
| +0.3% | +$650 | 0.03% | 181 |
|
|
2017
Q1 | $244K | Buy |
+1,579
| New | +$218K | 0.03% | 179 |
|
|
2016
Q2 | – | Sell |
-2,569
| Closed | -$201K | – | 211 |
|
|
2016
Q1 | $201K | Sell |
2,569
-289
| -10% | -$20.8K | 0.03% | 189 |
|
|
2015
Q4 | $208K | Hold |
2,858
| – | – | 0.03% | 191 |
|
|
2015
Q3 | $212K | Sell |
2,858
-1,226
| -30% | -$87.8K | 0.03% | 189 |
|
|
2015
Q2 | $262K | Buy |
+4,084
| New | +$283K | 0.03% | 230 |
|
Other funds holding IDXX
WMS Partners's IDXX Position: Q1 2025 in Review
WMS Partners sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 657 shares — an estimated $272K sold.
WMS Partners first reported a position in IDXX in Q2 2015 and held it in 36 quarters. The position peaked at $1.05M in Q4 2021. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.
- WMS Partners reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
- WMS Partners sold 657 Idexx Laboratories shares in Q1 2025, an estimated $272K.
- WMS Partners first reported a position in Idexx Laboratories in Q2 2015 and held it in 36 quarters.
- WMS Partners's Idexx Laboratories position peaked at $1.05M in Q4 2021.
- 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.
Based on WMS Partners's 13F filing for Q1 2025.